T. Rowe Price Associates’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.89M Buy
33,169
+5,135
+18% +$298K ﹤0.01% 1847
2025
Q4
$1.42M Buy
28,034
+798
+3% +$40.8K ﹤0.01% 1920
2025
Q3
$1.36M Buy
27,236
+1,203
+5% +$55.1K ﹤0.01% 1921
2025
Q2
$1.04M Buy
26,033
+921
+4% +$34.3K ﹤0.01% 1974
2025
Q1
$880K Buy
25,112
+625
+3% +$24.6K ﹤0.01% 2021
2024
Q4
$958K Sell
24,487
-4,545
-16% -$163K ﹤0.01% 1987
2024
Q3
$853K Buy
29,032
+979
+3% +$29.9K ﹤0.01% 2039
2024
Q2
$867K Buy
28,053
+337
+1% +$10.7K ﹤0.01% 1956
2024
Q1
$991K Sell
27,716
-756
-3% -$27.3K ﹤0.01% 1923
2023
Q4
$1.11M Buy
28,472
+1,607
+6% +$52K ﹤0.01% 1818
2023
Q3
$710K Buy
26,865
+403
+2% +$12.2K ﹤0.01% 1955
2023
Q2
$926K Buy
26,462
+1,763
+7% +$56.2K ﹤0.01% 1851
2023
Q1
$819K Buy
24,699
+1,869
+8% +$57.8K ﹤0.01% 1884
2022
Q4
$583K Buy
22,830
+5,604
+33% +$166K ﹤0.01% 2064
2022
Q3
$628K Buy
17,226
+1,182
+7% +$51.2K ﹤0.01% 2007
2022
Q2
$768K Buy
16,044
+1,441
+10% +$66.8K ﹤0.01% 2024
2022
Q1
$772K Buy
14,603
+594
+4% +$31.3K ﹤0.01% 2129
2021
Q4
$719K Sell
14,009
-1,165
-8% -$68.7K ﹤0.01% 2200
2021
Q3
$1.01M Sell
15,174
-620
-4% -$48.4K ﹤0.01% 2058
2021
Q2
$1.45M Sell
15,794
-953
-6% -$93.9K ﹤0.01% 1885
2021
Q1
$2.04M Sell
16,747
-3,287
-16% -$547K ﹤0.01% 1706
2020
Q4
$3.07M Sell
20,034
-383
-2% -$54K ﹤0.01% 1525
2020
Q3
$2.64M Sell
20,417
-831
-4% -$109K ﹤0.01% 1498
2020
Q2
$2.39M Buy
21,248
+1,258
+6% +$129K ﹤0.01% 1502
2020
Q1
$1.52M Sell
19,990
-932
-4% -$86.4K ﹤0.01% 1570
2019
Q4
$2.13M Buy
20,922
+1,169
+6% +$116K ﹤0.01% 1581
2019
Q3
$2.02M Buy
19,753
+323
+2% +$32.9K ﹤0.01% 1573
2019
Q2
$2.25M Buy
19,430
+263
+1% +$28.3K ﹤0.01% 1566
2019
Q1
$2.02M Buy
19,167
+881
+5% +$98.9K ﹤0.01% 1590
2018
Q4
$2.06M Buy
18,286
+3,744
+26% +$462K ﹤0.01% 1551
2018
Q3
$2.35M Sell
14,542
-1,036
-7% -$147K ﹤0.01% 1579
2018
Q2
$1.85M Buy
15,578
+45
+0.3% +$5.51K ﹤0.01% 1617
2018
Q1
$1.83M Buy
15,533
+54
+0.3% +$6.1K ﹤0.01% 1599
2017
Q4
$1.59M Sell
15,479
-1,010
-6% -$90.6K ﹤0.01% 1639
2017
Q3
$1.32M Sell
16,489
-500
-3% -$36.1K ﹤0.01% 1694
2017
Q2
$1.14M Buy
16,989
+1,000
+6% +$60.4K ﹤0.01% 1730
2017
Q1
$817K Buy
15,989
+2,200
+16% +$116K ﹤0.01% 1866
2016
Q4
$708K Buy
13,789
+1,400
+11% +$73.4K ﹤0.01% 1908
2016
Q3
$742K Sell
12,389
-494,077
-98% -$28.4M ﹤0.01% 1861
2016
Q2
$29.2M Buy
506,466
+1,800
+0.4% +$120K 0.01% 976
2016
Q1
$38.9M Buy
504,666
+94,530
+23% +$6.1M 0.01% 864
2015
Q4
$26.1M Buy
410,136
+3,880
+1% +$250K 0.01% 997
2015
Q3
$27.2M Buy
406,256
+68,960
+20% +$4.91M 0.01% 980
2015
Q2
$22.8M Buy
337,296
+7,966
+2% +$562K ﹤0.01% 1092
2015
Q1
$23.1M Buy
329,330
+156,415
+90% +$10.6M ﹤0.01% 1084
2014
Q4
$11.6M Buy
+172,915
New +$11.4M ﹤0.01% 1279
2014
Q2
Sell
-44,000
Closed -$2.98M 2546
2014
Q1
$2.98M Sell
44,000
-24,900
-36% -$1.85M ﹤0.01% 1500
2013
Q4
$4.9M Sell
68,900
-11,600
-14% -$899K ﹤0.01% 1437
2013
Q3
$6.15M Sell
80,500
-201,060
-71% -$13.9M ﹤0.01% 1387
2013
Q2
$18.3M Buy
+281,560
New +$15.1M ﹤0.01% 1088

Other funds holding PRLB

T. Rowe Price Associates's PRLB Position: Q1 2026 in Review

T. Rowe Price Associates increased its Protolabs (PRLB) stake by 18% in Q1 2026, buying an estimated $298K and bringing the position to 33,169 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

T. Rowe Price Associates first reported a position in PRLB in Q2 2013 and has held it in 50 quarters since. The position peaked at $38.9M in Q1 2016. 262 funds tracked by Wall St. Rank hold PRLB as of Q1 2026.

  • T. Rowe Price Associates held 33,169 shares of Protolabs worth $1.89M as of Q1 2026.
  • T. Rowe Price Associates bought 5,135 Protolabs shares in Q1 2026, an estimated $298K.
  • Protolabs made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1847 holding.
  • T. Rowe Price Associates first reported a position in Protolabs in Q2 2013 and has held it in 50 quarters since.
  • T. Rowe Price Associates's Protolabs position peaked at $38.9M in Q1 2016.
  • 262 funds tracked by Wall St. Rank held Protolabs as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.